By Syndicated Content
Apr 21, 2021 7:21 AM
BANGKOK (Reuters) - Thailand will continue to use COVID-19 vaccine from China s Sinovac Biotech following six reports of unusual stroke-like side effects among recipients, government-appointed experts said on Wednesday.
Six medical personnel in Rayong province, east of Bangkok, who were inoculated earlier this month experienced symptoms similar to those of a stroke, the panel of experts said, including drowsiness and numbness in the limbs.
They have since recovered after being given stroke treatments and no blood clots were found.
The announcement comes amid heightened global focus on efficacy levels and possible side-effects from different COVID-19 vaccines, and temporary suspensions in some countries, including over reports of blood clots among some recipients.
Airline Losses Pile Up; France to Ease Some Curbs: Virus Update Bloomberg 47 mins ago Bloomberg News
(Bloomberg) Airlines’ losses will amount to as much as $48 billion this year, the industry’s trade group said, widening its estimate by about a quarter as virus flare-ups and mutations push back the restart of global travel.
France plans to lift curbs on regional movement and reopen schools in coming weeks, while leaving a curfew in place, the government spokesman said. In Germany, the lower house of parliament backed Chancellor Angela Merkel’s controversial lockdown law.
India is driving a surge of cases in Asia, reporting nearly 300,000 new infections and a record of more than 2,000 deaths on Wednesday. In Japan, Tokyo and Osaka will ask the government to declare a state of emergency, looking to contain surging cases ahead of the Olympics. The United Arab Emirates is considering restrictions on people who haven’t taken a vaccine despite being eligi